241 related articles for article (PubMed ID: 33679686)
1. Immunotherapy: A Potential Approach for High-Grade Spinal Cord Astrocytomas.
Hu J; Liu T; Han B; Tan S; Guo H; Xin Y
Front Immunol; 2020; 11():582828. PubMed ID: 33679686
[TBL] [Abstract][Full Text] [Related]
2. Spinal cord astrocytomas: progresses in experimental and clinical investigations for developing recovery neurobiology-based novel therapies.
Teng YD; Abd-El-Barr M; Wang L; Hajiali H; Wu L; Zafonte RD
Exp Neurol; 2019 Jan; 311():135-147. PubMed ID: 30243796
[TBL] [Abstract][Full Text] [Related]
3. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
[TBL] [Abstract][Full Text] [Related]
4. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for Glioblastoma: Current Progress and Challenges.
Yu MW; Quail DF
Front Immunol; 2021; 12():676301. PubMed ID: 34054867
[TBL] [Abstract][Full Text] [Related]
6. Prospects of biological and synthetic pharmacotherapies for glioblastoma.
Altshuler DB; Kadiyala P; Nuñez FJ; Nuñez FM; Carney S; Alghamri MS; Garcia-Fabiani MB; Asad AS; Nicola Candia AJ; Candolfi M; Lahann J; Moon JJ; Schwendeman A; Lowenstein PR; Castro MG
Expert Opin Biol Ther; 2020 Mar; 20(3):305-317. PubMed ID: 31959027
[No Abstract] [Full Text] [Related]
7. Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.
Bracci L; Fragale A; Gabriele L; Moschella F
Front Immunol; 2020; 11():582744. PubMed ID: 33193392
[TBL] [Abstract][Full Text] [Related]
8. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
Shi T; Song X; Wang Y; Liu F; Wei J
Front Immunol; 2020; 11():683. PubMed ID: 32411132
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
[TBL] [Abstract][Full Text] [Related]
10. Vaccine strategies for glioblastoma: progress and future directions.
Jackson C; Ruzevick J; Brem H; Lim M
Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
[TBL] [Abstract][Full Text] [Related]
11. Intramedullary spinal cord astrocytomas in children.
Townsend N; Handler M; Fleitz J; Foreman N
Pediatr Blood Cancer; 2004 Nov; 43(6):629-32. PubMed ID: 15390309
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for esophageal cancer: a 2019 update.
Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD133 as a Putative Prognostic Biomarker to Predict Intracranial Dissemination of Primary Spinal Cord Astrocytoma.
Inoue T; Endo T; Nakamura T; Shibahara I; Endo H; Tominaga T
World Neurosurg; 2018 Feb; 110():e715-e726. PubMed ID: 29180077
[TBL] [Abstract][Full Text] [Related]
14. Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients.
Chamoun RB; Alaraj AM; Al Kutoubi AO; Abboud MR; Haddad GF
Acta Neurochir (Wien); 2006 Feb; 148(2):175-9; discussion 180. PubMed ID: 16374565
[TBL] [Abstract][Full Text] [Related]
15. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
Cui X; Wang Q; Kang C
Front Immunol; 2021; 12():788733. PubMed ID: 34777399
[No Abstract] [Full Text] [Related]
16. Spinal Cord Neoplasms.
McFaline-Figueroa JR
Continuum (Minneap Minn); 2024 Feb; 30(1):99-118. PubMed ID: 38330474
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic treatments for spinal and peripheral nerve tumors: a primer.
Bryant JP; Lu VM; Govindarajan V; Perez-Roman RJ; Levi AD
Neurosurg Focus; 2022 Feb; 52(2):E8. PubMed ID: 35104797
[TBL] [Abstract][Full Text] [Related]
18. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
19. Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database.
Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Jallo GI
J Neurosurg Pediatr; 2017 Jun; 19(6):711-719. PubMed ID: 28362182
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in intramedullary astrocytomas: a literature review.
Benes V; Barsa P; Benes V; Suchomel P
Eur Spine J; 2009 Oct; 18(10):1397-422. PubMed ID: 19562388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
